Violeta Yu
Impact in
- Molecular Biology top 2%
- Cell death mechanisms and regulation
- RNA Interference and Gene Delivery
- Mitochondrial Function and Pathology
- Immunology top 5%
- interferon and immune responses
Papers in
-
- Ion channel regulation and function 7
- Receptor Mechanisms and Signaling 3
- Epigenetics and DNA Methylation 3
- Oncology 9
- Cytokine Signaling Pathways and Interactions 4
- Co-authors
- Donald W. Nicholson (3 shared papers)Ting-Ting Yamin (2 shared papers)John P. Vaillancourt (2 shared papers)Douglas K. Miller (2 shared papers)Ambereen Ali (2 shared papers)Michel Gallant (1 shared paper)Patrick R. Griffin (1 shared paper)Yves Gareau (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (7 papers)SLAS DISCOVERY (3 papers)Journal of Medicinal Chemistry (3 papers)Assay and Drug Development Technologies (3 papers)Cancer Research (2 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Violeta Yu
29 papers receiving 4.3k citations
Violeta Yu's Hit Papers
Peers
Comparison fields: 5 of 119
- Molecular Biology 3.1k
- Immunology 740
- Cancer Research 458
- Oncology 729
- Toxicology 95
Countries citing papers authored by Violeta Yu
This map shows the geographic impact of Violeta Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violeta Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violeta Yu more than expected).
Fields of papers citing papers by Violeta Yu
This network shows the impact of papers produced by Violeta Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violeta Yu. The network helps show where Violeta Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Violeta Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis Hit paper breakdown → | 1995 | 3686 |
| 2 | 1995 | 256 | |
| 3 | 2008 | 66 | |
| 4 | 2003 | 66 | |
| 5 | 2005 | 42 | |
| 6 | 2016 | 41 | |
| 7 | 2012 | 39 | |
| 8 | 2008 | 38 | |
| 9 | 2018 | 37 | |
| 10 | 2011 | 34 | |
| 11 | 2024 | 25 | |
| 12 | 2009 | 25 | |
| 13 | 2013 | 20 | |
| 14 | 2013 | 20 | |
| 15 | 1995 | 16 | |
| 16 | 2006 | 15 | |
| 17 | 2012 | 11 | |
| 18 | 2008 | 10 | |
| 19 | 2018 | 9 | |
| 20 | 2017 | 6 |
About Violeta Yu
Violeta Yu is a scholar working on Molecular Biology, Oncology, Genetics, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 29 papers that have together received 4.5k indexed citations. Recurring topics across this work include Ion channel regulation and function (7 papers), Cytokine Signaling Pathways and Interactions (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Receptor Mechanisms and Signaling (3 papers), Epigenetics and DNA Methylation (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). The work is most often cited by research in Molecular Biology (3.1k citations), Immunology (740 citations), Cancer Research (458 citations), Oncology (729 citations) and Toxicology (95 citations). Violeta Yu has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Donald W. Nicholson, Ting-Ting Yamin, John P. Vaillancourt, Douglas K. Miller, Ambereen Ali, Michel Gallant, Patrick R. Griffin, Yves Gareau, Marc Labelle and Yuri Lazebnik. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, SLAS DISCOVERY, Journal of Medicinal Chemistry, Assay and Drug Development Technologies and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.